Skip to content

A study to compare how well EMLA (Prilox) cream reduces pain when it is applied 1 hour before iv cannulation site in comparison to a placebo.

A study to compare the efficacy of EMLA (Prilox) cream vs placebo application 1 hour prior to IV cannulation on procedural analgesia. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/12/078300
Enrollment
30
Registered
2024-12-18
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: NIL: NIL

Sponsors

Smt Bhikiben Kanjibhai Shah Medical Institute and Research Cen
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: INCLUSION CRITERIA : 1) Patient willing to sign the written & informed consent. 2) Patients posted for elective surgeries. 3) Patients belonging to American Society of anesthesiologists grade I, Il amd III

Exclusion criteria

Exclusion criteria: EXCLUSION CRITERIA: 1) Patients with known hypersensitivity to EMLA cream or any other local anesthetics. 2) Patients with methemoglobinemia or on drugs that may cause methemoglobinemia. 3) Patients with mental illness. 4) Patients with open wounds on dorsum of hand.

Design outcomes

Primary

MeasureTime frame
This observational study will help us to assess the efficacy of EMLA (PRILOX) cream when compared to placebo application 1 hour prior to iv cannulation. Timepoint: Baseline 60 minutes before intravenous cannulation

Secondary

MeasureTime frame
This observational study will help us to assess the reduction in VAS score following application of EMLA (PRILOX) cream v/s placebo application 1 hour prior to iv cannulation.Timepoint: 1 hour prior to iv cannulation.

Countries

India

Contacts

Public ContactDr Dinesh Chauhan

Smt. Bhikiben Kanjibhai Shah Medical Institute and Research Centre

dr.dinesh77@gmail.com9099014672

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026